Clinical studies recruiting near Montpellier

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU de Montpellier - Département d'Hématologie Clinique · The Lymphoma Academic Research Organisation · NCT07018752 Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Phase 3 · CHU de Montpellier · TBF Genie Tissulaire · NCT06450470 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU de Montpellier · Fondation Hôpital Saint-Joseph · NCT05674994 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)
NA · Department of Neurology/ Stroke Unit, Hôpital Gui de Chaulia · University Hospital, Montpellier · NCT05832762 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHI Montpellier · Princess Maxima Center for Pediatric Oncology · NCT05327894 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Centre de Cancérologie du Grand Montpellier · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0172 · Bristol-Myers Squibb · NCT06929273 Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Vers
NA · ICM Val d'Aurelle · Institut du Cancer de Montpellier - Val d'Aurelle · NCT06415266 Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
Phase N/A · Montpellier University Hospital · University Hospital, Montpellier · NCT05394922 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · CHU de Montpellier · Alfasigma S.p.A. · NCT06865417 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · Chu Montpellier · University Hospital, Lille · NCT03728049 Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Phase 2 · Centre Hospitalier Universitaire de Montpellier · Center Eugene Marquis · NCT05265208 Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
NA · AIDER · University Hospital, Montpellier · NCT02813642 Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fib
Phase N/A · CHU de Montpellier - Hôpital Arnaud de Villeneuve · University Hospital, Montpellier · NCT06602869 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Montpellier · University Hospital, Limoges · NCT04592003 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · CHU de Montpellier · Ad scientiam · NCT05566769 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital Arnaud de Villeneuve · Hospices Civils de Lyon · NCT03593317 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · CHU Montpellier · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0001 · Bristol-Myers Squibb · NCT07291076 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHU Montpellier · Nantes University Hospital · NCT06244433 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Lapeyronie · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Phase 2 · CHU de Montpellier · Centre Hospitalier Universitaire de Besancon · NCT06425133 Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?
NA · University Hospital, Montpellier · University Hospital, Montpellier · NCT05629871 Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
Phase 3 · CHU de MONTPELLIER · Centre Hospitalier Universitaire de Nice · NCT05902221 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Institut du Cancer de Montpellier - Val d'Aurelle · NovoCure Ltd. · NCT06924099 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections
Phase N/A · Service Pédiatrie néonatale et réanimations CHU Montpellier · Hospices Civils de Lyon · NCT06656104 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Chu de Montpellier · Hospices Civils de Lyon · NCT05444712

Look up another city

Look up another condition